Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05588934 · ClinicalTrials.gov registry record · NA
Caffeine Optimization Versus Standard Caffeine Dosage (2B-2)
A NA study of Sleep Deprivation and Caffeine, sponsored by University of Arizona.
- Recruiting
- Registry status
- NA
- Development phase
- 180
- Enrollment target
- 2
- Study locations
NCT05588934 is a NA study of Sleep Deprivation and Caffeine that is actively recruiting participants, run by University of Arizona. The registered enrollment target is 180 participants, above the 86-participant average among 34 other Sleep Deprivation trials with a reported enrollment target (109% higher). The trial reports 2 study locations across 1 state.
The verdict
NCT05588934, a NA study of Sleep Deprivation and Caffeine, is actively recruiting participants, sponsored by University of Arizona.
- RECRUITING
- Registry status
- NA
- Development phase
- 180 participants
- Enrollment target
- 2
- Study locations
Study Summary
This clinical trial will be a comparison between personalized recommended caffeine dosing regimen versus the standard recommended caffeine dosing regimen for sustaining performance during sleep deprivation and minimizing side effects and subsequent sleep disruption. The questions this study aims to answer are: Whether the personalized caffeine recommendations improve vigilance, sleepiness, and cognition after total sleep deprivation, compared to standard recommendations; Whether the personalized caffeine recommendation better addresses the physical and emotional side effects of total sleep deprivation, compared to standard recommendations; And whether personalized caffeine recommendations aids in better recovery sleep after total sleep deprivation, compared to standard recommendations. Participants will be asked to: 1. Complete a 13-day at-home portion, wearing an actigraph watch to measure activity and sleep, and complete motor vigilance tests up to six times a day. 2. Complete a 4-day in-lab portion, where participants will have to complete one night of baseline sleep, undergo 62-hours of total sleep deprivation, and then complete one night of recovery sleep. 3. During the in-lab portion of the study, participants will be asked to complete more motor vigilance tests. Researchers will be comparing the personalized caffeine recommendation group against the standard caffeine recommendation to see if it is better at addressing each of the main questions.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Caffeine Gum
- OTHER Placebo Gum
Study Locations (2)
Arizona
- University of Arizona - Tucson
- University of Arizona Psychiatry Department - Tucson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2023-06-09 |
| Est. Completion | 2026-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05588934
The ClinicalTrials.gov registry entry for NCT05588934 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 180 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 86-participant average among 34 other Sleep Deprivation trials with a reported enrollment target (109% higher). The listed sponsor is University of Arizona, which has 349 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Sleep Deprivation appearing as the primary indexed condition, and to 2 interventions - of which Caffeine Gum is the first listed.
NCT05588934 reports 2 study locations spanning 1 distinct geographic area - top geographies include Arizona.
Frequently Asked Questions
What is clinical trial NCT05588934 about?
NCT05588934 is a clinical study titled "Caffeine Optimization Versus Standard Caffeine Dosage (2B-2)". This clinical trial will be a comparison between personalized recommended caffeine dosing regimen versus the standard recommended caffeine dosing regimen for sustaining performance during sleep deprivation and minimizing side effects and subsequent sleep disruption. The questions this study aims to ...
What is the current status of trial NCT05588934?
This trial is currently recruiting. It is a NA study. The enrollment target is 180 participants. The study started on 2023-06-09. Estimated completion is 2026-03.
What conditions does trial NCT05588934 study?
This clinical trial studies the following conditions: Sleep Deprivation, Caffeine.
What interventions are being tested in trial NCT05588934?
The interventions under investigation include: Caffeine Gum (DIETARY_SUPPLEMENT), Placebo Gum (OTHER).
Who is sponsoring clinical trial NCT05588934?
This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05588934 being conducted?
This trial has 2 study locations across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sleep Deprivation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Biomarkers of Increased Free Living Sleep Time
RECRUITING · NA
-
The Function of Biphasic Sleep in Infants
RECRUITING · NA
-
Transcranial Electrical Stimulation (TES) at Slow Oscillation (SO) Frequency During NREM Sleep
RECRUITING · NA
-
Reestablishing Sleep and Circadian Alignment in Medical Intensive Care Unit (MICU) Patients Via a Mechanistic RCT of an Sleep Chronobundle
RECRUITING · NA
-
Menstrual-phase-dependent Differences in Response to Sleep Loss
RECRUITING · NA
-
Acoustic Stimulation During Restricted Sleep After Sleep Deprivation
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.